Activated inflammasome initiates caspase-1 and determines IL-1β and IL-18 pro-inflammatory cytokines production, increasing liver inflammation, fibrosis, and damage in ADL and NAFLD [65,66,67]. Here, IL18 is linked to metabolic dysfunction-associated steatotic liver disease.